Drug development and diagnostics without limitations

Slingshot’s revolutionary technology is a new paradigm for any cell-based application, including drug discovery, clinical trials, medical testing, and cell therapy manufacturing.

High Throughput + Precision Manufacturing

We envisioned limitless drug development when we founded this company over 10 years ago. Our R&D experience revealed the shortcomings of biologically-derived reagents, leading to unequal access to diagnostics and therapies.


We knew there had to be a better way. And there is.


We created FlowCytes™ using biochemistry and polymer chemistry. These synthetic cells are printed on demand. Slingshot’s technology lowers costs, shortens timelines, and enhances stability and accessibility.

Our mission is to accelerate the discovery of innovative diagnostics and treatments that will improve and extend human life.

We strive for global leadership in cell technologies to enhance health. By uniting minds worldwide, we advance science with passion. Through collaboration, we foster innovation and embrace diversity. Our partnerships with researchers help them achieve goals faster. We deliver quality products while adhering to ethical standards.

Our north star is to make healthcare more accessible around the world. We will do that by:

Frame 1000007687-effectapp 1.png

Advancing cell biology to drive innovative solutions

Our vision is to advance the understanding of cell biology, especially in cancer and rare diseases, to help scientists and physicians focus on what they do best—creating innovative cures to treat patients.

Image bg - 10-effectapp 1.png

Making diagnostic testing simple and accessible

Our vision is to advance the understanding of cell biology, especially in cancer and rare diseases, to help scientists and physicians focus on what they do best—creating innovative cures to treat patients.

Image bg - 10-effectapp 1.jpg

Making personalized therapeutics a reality

Our vision is to advance the understanding of cell biology, especially in cancer and rare diseases, to help scientists and physicians focus on what they do best—creating innovative cures to treat patients.

Leadership

The people building Slingshot.

Glenn Bilawsky

Glenn Bilawsky

Chief Executive Officer

Nimisha Srivastava

Nimisha Srivastava

Chief Operating Officer

Jim Snook

Jim Snook

Senior Vice President, Global Sales

Toney Szeto

Toney Szeto

Vice President, Head of Finance

Josh Haydon

Josh Haydon

Head of Marketing

Nicholas Perez

Nicholas Perez

Associate Director of HR

Board of Directors

Advisors shaping our direction.

Dr. Jeffrey Kim

Founder, Board Director

Andrew Lee

Board Director

Patrick Weiss

Board Director

Corey Ritter

Board Director

Keith Crandell

Board Observer

Ron Silberman

Board Director

Philip Austin

Board Observer

Nicolas Barthelemy

Chair of The Board

Our Investors

myeloma solutions fund
ARCH
Northpond ventures
anterra capital
tao capital partners
myeloma solutions fund
ARCH
Northpond ventures
anterra capital
tao capital partners
myeloma solutions fund
ARCH
Northpond ventures
anterra capital
tao capital partners